Led by $150m venture financing of WuXi Diagnostic Investment (Cayman), total medical devices industry venture financing deals worth $912.88m were announced in Asia-Pacific in Q1 2021, according to GlobalData’s deals database.
The value marked a decrease of 37.04% over the previous quarter and a drop of 19.9% when compared with the last four-quarter average of $1.14bn.
Asia-Pacific held a 19.85% share of the global medical devices industry venture financing deal value that totalled $4.6bn in Q1 2021. With a 19.35% share and deals worth $889.91m, China was the top country in Asia-Pacific’s venture financing deal value across medical devices industry.
